Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q8NET8: Variant p.Gly573Ser

Transient receptor potential cation channel subfamily V member 3
Gene: TRPV3
Feedback?
Variant information Variant position: help 573 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glycine (G) to Serine (S) at position 573 (G573S, p.Gly573Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In OLMS1; gain of function mutation; results in constitutive channel activation. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 573 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 790 The length of the canonical sequence.
Location on the sequence: help LAMALGWANMLYYTRGFQSM G MYSVMIQKVILHDVLKFLFV The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         LAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFV

Mouse                         LAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFV
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 790 Transient receptor potential cation channel subfamily V member 3
Topological domain 567 – 589 Cytoplasmic
Helix 570 – 585



Literature citations
Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome.
Lin Z.; Chen Q.; Lee M.; Cao X.; Zhang J.; Ma D.; Chen L.; Hu X.; Wang H.; Wang X.; Zhang P.; Liu X.; Guan L.; Tang Y.; Yang H.; Tu P.; Bu D.; Zhu X.; Wang K.; Li R.; Yang Y.;
Am. J. Hum. Genet. 90:558-564(2012)
Cited for: VARIANTS OLMS1 SER-573; CYS-573 AND GLY-692; CHARACTERIZATION OF VARIANTS OLMS1 SER-573; CYS-573 AND GLY-692; Recurrent heterozygous missense mutation, p.Gly573Ser, in the TRPV3 gene in an Indian boy with sporadic Olmsted syndrome.
Lai-Cheong J.E.; Sethuraman G.; Ramam M.; Stone K.; Simpson M.A.; McGrath J.A.;
Br. J. Dermatol. 167:440-442(2012)
Cited for: VARIANT OLMS1 SER-573;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.